共 50 条
- [1] Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : 341 - 348
- [2] Late Side Effects in Men With Intermediate- and High-Risk Prostate Cancer Treated With High-Dose Radiation Therapy and Androgen Deprivation (DART 01/05): Secondary Endpoints From a Phase 3 Clinical Trial [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S105 - S105
- [3] Prognostic Value of Testosterone Levels Following Androgen Deprivation And High Dose Radiotherapy In Localized Prostate Cancer: Results From Dart 01/05 Phase III Trial [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E858 - E858
- [4] High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial [J]. LANCET ONCOLOGY, 2022, 23 (05): : 671 - 681
- [6] High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial [J]. LANCET ONCOLOGY, 2015, 16 (03): : 320 - 327
- [10] Randomized Phase 3 Trial of Adjuvant Androgen Deprivation in Combination With High-Dose Conformal Radiation Therapy in Intermediate- and High-Risk Localized Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S1 - S1